P&G Hygiene

When is the next results date for P&G Hygiene?

No Upcoming Board Meetings

Who are the peers of the P&G Hygiene?

P&G Hygiene's peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Gillette India, Emami, Hatsun Agro, Bikaji Foods, and Godrej Agrovet. P&G Hygiene has the lowest 1-year return at -16.17%, while Gillette India leads with 32.82%.

Peers: The peers of P&G Hygiene are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Gillette India, Emami, Hatsun Agro, Bikaji Foods, and Godrej Agrovet.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, Britannia Inds., Gillette India, Emami, and P&G Hygiene, while Good management risk is found at Hind. Unilever, Godrej Consumer, Hatsun Agro, Bikaji Foods, and Godrej Agrovet. Below Average growth is noted for Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, P&G Hygiene, Gillette India, Emami, and the rest, while Good growth is seen at Hatsun Agro and Average growth at Bikaji Foods.<BR><BR>Return Snapshot: Gillette India has the highest 1-year return at 32.82%, while P&G Hygiene has the lowest at -16.17%. P&G Hygiene's return is significantly lower than all peers. Additionally, the six-month return is negative for P&G Hygiene, Hind. Unilever, ITC, Godrej Consumer, Emami, and Hatsun Agro.

Who are in the management team of P&G Hygiene?

As of June 2022, the management team of P&G Hygiene includes A K Gupta, Sonali Dhawan, Karthik Natarajan, Pramod Agarwal, Gagan Sawhney, Meena Ganesh, Ghanashyam Hedge, Chittranjan Dua, Krishnamurthy Narayanan Iyer, L. V. Vaidyanathan, and Gurcharan Das, with roles ranging from directors to managing director and chairman.

As of June 2022, the management team of P&G Hygiene includes the following individuals:<BR><BR>1. A K Gupta - Independent Director<BR>2. Sonali Dhawan - Director<BR>3. Karthik Natarajan - Director<BR>4. Pramod Agarwal - Director<BR>5. Gagan Sawhney - Director<BR>6. Meena Ganesh - Independent Director<BR>7. Ghanashyam Hedge - Executive Director & Secretary<BR>8. Chittranjan Dua - Chairman & Independent Director<BR>9. Krishnamurthy Narayanan Iyer - Independent Director<BR>10. L. V. Vaidyanathan - Managing Director<BR>11. Gurcharan Das - Independent Director<BR><BR>Each member holds a significant role within the company, contributing to its governance and strategic direction.

What does P&G Hygiene do?

Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) manufactures and sells branded fast-moving consumer goods in the femcare and healthcare sectors. As of March 2025, it reported net sales of ₹9,891 Cr and a net profit of ₹1,561 Cr, with a market cap of ₹42,929 Cr.

Overview: <BR>Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling branded packaged fast moving consumer goods in the femcare and healthcare businesses, operating within the FMCG industry and classified as a large-cap company.<BR><BR>History: <BR>P&GHHCL was incorporated in an unspecified year and has maintained its status as a key player in the FMCG sector. The latest quarterly results reported are for March 2025, showcasing the company's financial performance.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 9,891 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 1,561 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 42,929 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 60.00 <BR>Industry P/E: 56 <BR>Dividend Yield: 1.55% <BR>Debt Equity: -0.83 <BR>Return on Equity: 75.88% <BR>Price to Book: 45.27<BR><BR>Contact Details: <BR>Address: P & G Plaza Chakala, Cardinal Gracias Rd Andheri(E) Mumbai Maharashtra : 400099 <BR>Tel: 91-22-28266000 <BR>Email: investorpghh.i@pg.com <BR>Website: http://www.in.pg.com

Who are the top shareholders of the P&G Hygiene?

The top shareholder of P&G Hygiene is Procter And Gamble Overseas India B.V. with 68.73%. Other significant shareholders include mutual funds at 8.26%, individual investors at 9.76%, and Foreign Institutional Investors at 1.33%.

The top shareholders of P&G Hygiene include Procter And Gamble Overseas India B.V., which holds the largest stake at 68.73%. Additionally, mutual funds collectively hold 8.26% through 15 schemes, with the SBI Focused Equity Fund being the highest public shareholder at 5.73%. Foreign Institutional Investors (FIIs) hold 1.33% through 108 entities, while individual investors account for 9.76% of the shareholding. There are no pledged promoter holdings reported.

How big is P&G Hygiene?

As of 24th July, Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 42,511.00 Cr, with recent net sales of 4,295.54 Cr and a net profit of 717.65 Cr. Shareholder's funds are 774.86 Cr, and total assets amount to 1,783.69 Cr.

As of 24th July, Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 42,511.00 Cr, categorizing it as a Large Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 4,295.54 Cr and a Net Profit of 717.65 Cr.<BR><BR>For the latest annual period ending June 2024, Shareholder's Funds amounted to 774.86 Cr, while Total Assets were reported at 1,783.69 Cr.

Is P&G Hygiene technically bullish or bearish?

As of November 3, 2025, P&G Hygiene's trend is mildly bearish, influenced by daily moving averages and monthly MACD signals, despite some mildly bullish indicators on the weekly MACD.

As of 3 November 2025, the technical trend for P&G Hygiene has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating bearish momentum and the monthly MACD showing a bearish signal. The weekly MACD is mildly bullish, but this is offset by the monthly Bollinger Bands and KST both indicating bearish conditions. The RSI shows no signal in both weekly and monthly time frames, suggesting a lack of strong momentum in either direction. Overall, the mixed signals across different indicators reflect a weak bearish sentiment.

How has been the historical performance of P&G Hygiene?

P&G Hygiene has shown consistent growth in net sales, reaching 4,191.57 Cr in June 2024, but experienced a slight decline in profit after tax and cash flow from operating activities. Total assets and liabilities decreased, indicating potential restructuring despite strong sales performance.

Answer:<BR>The historical performance of P&G Hygiene shows a consistent upward trend in net sales and operating profit over the years, with net sales reaching 4,191.57 Cr in June 2024, up from 3,905.21 Cr in June 2023 and 3,792.45 Cr in June 2022. Operating profit also increased to 1,022.69 Cr in June 2024 from 909.21 Cr in June 2023. However, profit after tax saw a slight decline to 675.02 Cr in June 2024 from 678.14 Cr in June 2023. The company's total assets decreased to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023, while total liabilities also fell to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023. Cash flow from operating activities decreased to 470.00 Cr in June 2024 from 825.00 Cr in June 2023, indicating a tightening in cash generation.<BR><BR>Breakdown:<BR>P&G Hygiene has demonstrated a robust growth trajectory in net sales, which climbed from 3,001.99 Cr in June 2020 to 4,191.57 Cr in June 2024, reflecting a strong demand for its products. Operating profit, excluding other income, also showed a positive trend, increasing from 603.71 Cr in June 2020 to 970.44 Cr in June 2024, although the profit after tax slightly declined in the latest fiscal year. The company's total assets and liabilities both decreased in June 2024 compared to the previous year, suggesting a potential restructuring or reduction in operational scale. Furthermore, cash flow from operating activities has seen a decline, which may indicate challenges in maintaining liquidity despite the growth in sales and profits. Overall, while P&G Hygiene has achieved significant sales growth, the fluctuations in profit margins and cash flow warrant close monitoring.

Are Procter & Gamble Hygiene & Health Care Ltd. latest results good or bad?

Procter & Gamble Hygiene & Health Care Ltd. reported strong Q3 FY26 results with a 43.62% increase in net profit quarter-on-quarter, but only 1.10% year-on-year revenue growth raises concerns about sustainability. Despite improved margins and high return on equity, the stock's high valuation and recent decline suggest cautious investor sentiment.

Procter & Gamble Hygiene & Health Care Ltd. has reported mixed results for Q3 FY26. On one hand, the company achieved a net profit of ₹301.46 crore, which reflects a significant increase of 43.62% quarter-on-quarter and 12.24% year-on-year. Additionally, revenue for the quarter reached ₹1,259.91 crore, marking a 9.67% increase from the previous quarter, although the year-on-year growth was modest at just 1.10%.<BR><BR>The operating margin improved to 31.89%, the highest recorded in recent quarters, indicating effective cost management and operational efficiencies. The return on equity (ROE) remains exceptionally high at 81.87%, showcasing strong capital efficiency.<BR><BR>However, despite these positive sequential improvements, the year-on-year revenue growth of only 1.10% raises concerns about the sustainability of the company's growth trajectory. The stock is currently trading at a high P/E ratio of 46 times and a price-to-book value of 41 times, which is significantly above industry averages. This premium valuation, combined with the recent bearish technical indicators and a 20.52% decline from its 52-week high, suggests that investors may be cautious about the stock's future performance.<BR><BR>In summary, while the latest quarterly results show strong sequential performance and profitability, the overall growth concerns and high valuation multiples indicate a challenging environment for the company moving forward.

Should I buy, sell or hold Procter & Gamble Hygiene & Health Care Ltd.?

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share), with an ex-date of February 5, 2026. Despite the significant dividend, total returns have been negative over shorter periods, improving in the long term.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: 05 Feb 26<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the 6-month period, the price return was -14.1%, the dividend return was 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over the 2-year period, the price return was -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>During the 4-year period, the price return was -17.88%, the dividend return was 3.91%, culminating in a total return of -13.97%.<BR><BR>In the 5-year period, the price return was 5.2%, the dividend return was 7.14%, resulting in a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a trend of negative performance, particularly in the shorter time frames, with a more favorable outcome in the longer term.

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share) with an ex-date of August 28, 2025. Despite this, the company has experienced negative total returns over the past 1 to 4 years, though it showed a positive return of 12.34% over the last 5 years.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: Aug-28-2025<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>Over the past 3 months, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the last 6 months, the price return decreased by -14.1%, with a dividend return of 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over 2 years, the price return fell by -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>For the 4-year period, the price return decreased by -17.88%, with a dividend return of 3.91%, resulting in a total return of -13.97%.<BR><BR>In the 5-year span, the price return increased by 5.2%, the dividend return was 7.14%, leading to a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a challenging performance, particularly in the shorter terms, with negative returns dominating. However, the 5-year period shows a positive total return, suggesting potential recovery or growth in the long term.

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 17-Mar, Procter & Gamble Hygiene & Health Care Ltd. is facing a stock price decline to 10,003.45, down 1.64%. This decline is due to significant underperformance against benchmarks, a new 52-week low, and weak long-term growth prospects, despite some positive indicators.

As of 17-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 10,003.45, which reflects a change of -166.85 (-1.64%). This downward movement can be attributed to several factors highlighted in the data. <BR><BR>Firstly, the stock has been underperforming significantly against the benchmark, with a 1-year return of -26.12%, compared to a positive return of +2.56% for the Sensex. Over the past three years, the stock has consistently underperformed, generating negative returns while the broader market has seen growth. <BR><BR>Additionally, the stock has recently hit a new 52-week low of Rs. 9980, indicating a lack of investor confidence. The stock has also been on a consecutive decline for the last three days, with a total drop of -7.53% during this period. Furthermore, it is trading below its moving averages across various time frames, which typically signals a bearish trend.<BR><BR>Despite some positive indicators such as high management efficiency and strong quarterly results, the overall long-term growth prospects appear weak. The company has shown only modest growth in net sales and operating profit over the last five years, which raises concerns about its future performance. The high price-to-book value ratio of 34.9 suggests that the stock may be overvalued compared to its peers, contributing to its declining price.<BR><BR>In summary, the combination of poor long-term growth, consistent underperformance against benchmarks, and recent price declines has led to the falling stock price of Procter & Gamble Hygiene & Health Care Ltd.

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 18-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 10,001.00, reflecting a total decline of -7.66% over the last four days and a year-to-date decline of -22.70%. The stock's poor performance, reduced investor participation, and weak long-term growth prospects contribute to its current downward trend.

As of 18-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 10,001.00, which reflects a change of -2.45 (-0.02%). The stock has been on a downward trend, having fallen for the last four consecutive days, resulting in a total decline of -7.66% during this period. Additionally, the stock has reached a new 52-week low of Rs.9958.7 today.<BR><BR>The performance of the stock has been notably poor over various time frames, with a year-to-date decline of -22.70% and a one-year decline of -25.84%. This underperformance is further highlighted by the fact that the stock has consistently lagged behind the benchmark Sensex, which has shown a positive return of +1.86% over the same one-year period. Over the last three years, the stock has generated a return of -27.40%, while the Sensex has increased by +32.27%.<BR><BR>Investor participation has also decreased, with delivery volume falling by -29.25% compared to the five-day average. The stock is trading below its moving averages across various periods, indicating a bearish trend. Although the company has demonstrated high management efficiency with a return on equity (ROE) of 81.87% and low debt levels, the long-term growth prospects appear weak, with net sales growing at an annual rate of only 5.52% over the past five years. This has contributed to a perception of an expensive valuation, as indicated by a price-to-book value of 34.9.<BR><BR>In summary, the combination of declining stock performance, reduced investor participation, and poor long-term growth prospects has led to the current downward movement in Procter & Gamble Hygiene & Health Care Ltd.'s stock price.

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 19-Mar, Procter & Gamble Hygiene & Health Care Ltd. is facing a stock price decline to 9,903.90, down 1.2%. Key factors include hitting a new 52-week low, poor long-term growth prospects, and consistent underperformance against benchmarks.

As of 19-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 9,903.90, reflecting a change of -120.4 (-1.2%). This downward movement is influenced by several factors. <BR><BR>Firstly, the stock has hit a new 52-week low of Rs. 9889 today, indicating a significant drop in value. Over the past week, the stock has decreased by 8.55%, and it has shown a substantial decline of 23.45% year-to-date, compared to a 12.92% drop in the benchmark index, Sensex. This consistent underperformance is further highlighted by the stock's returns over the last year, which stand at -26.46%, contrasting sharply with the Sensex's minor decline of 1.65%.<BR><BR>Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a bearish trend. Although there has been a slight increase in investor participation, with delivery volume rising by 2.26% against the 5-day average, the overall sentiment remains negative.<BR><BR>Financially, while the company has reported positive results in terms of profit after tax and net sales growth, its long-term growth prospects appear poor, with net sales growing at an annual rate of only 5.52% over the last five years. The stock's high price-to-book value ratio of 34.5 indicates an expensive valuation, which may deter potential investors. Furthermore, the company has consistently underperformed against its benchmarks over the last three years, contributing to the negative perception surrounding its stock.<BR><BR>In summary, the combination of hitting a new low, poor long-term growth prospects, underperformance against benchmarks, and trading below moving averages are key factors contributing to the decline in Procter & Gamble Hygiene & Health Care Ltd.'s stock price.

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 20-Mar, Procter & Gamble Hygiene & Health Care Ltd. is facing a significant decline in its stock price, currently at Rs. 9,712.50, with a year-to-date drop of -24.93% and a 52-week low of Rs. 9,681.1, reflecting low investor confidence and poor long-term growth prospects. Despite some operational strengths, the stock's high valuation and consistent underperformance against benchmarks contribute to its bearish trend.

As of 20-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at Rs. 9,712.50, which reflects a change of -191.4 (-1.93%). The stock has been underperforming significantly, with a 1-week decline of -7.69% and a 1-month decline of -15.61%. Year-to-date, the stock has dropped by -24.93%, while over the past year, it has fallen by -28.00%. <BR><BR>Today, the stock hit a new 52-week low of Rs. 9,681.1, indicating a lack of investor confidence. The stock has also underperformed its sector by -2.16% today and has been on a consecutive downward trend for the last two days, with a total decline of -3.11% in that period. The trading activity shows that the stock is trading below its moving averages across various time frames, suggesting a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by -52.1% compared to the 5-day average.<BR><BR>Despite some positive factors such as high management efficiency and low debt levels, the company faces challenges with poor long-term growth, as evidenced by a low annual growth rate in net sales and operating profit over the last five years. The stock's valuation appears expensive relative to its earnings, with a high Price to Book Value ratio of 33.9. Furthermore, the stock has consistently underperformed against benchmarks, generating negative returns while profits have increased, indicating a disconnect between stock performance and financial health.<BR><BR>Overall, the combination of declining stock performance, low investor participation, and poor long-term growth prospects contributes to the falling stock price of Procter & Gamble Hygiene & Health Care Ltd.

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 23-Mar, Procter & Gamble Hygiene & Health Care Ltd. is facing a stock price decline to 9,509.00, down 2.14%, with a total drop of 5.14% over the last three days. The stock has consistently underperformed against the Sensex, with significant concerns about its long-term growth prospects and high valuation metrics.

As of 23-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 9,509.00, reflecting a change of -207.75 (-2.14%). The stock has been on a downward trend, having fallen for the last three days, with a total decline of -5.14% during this period. Additionally, the stock hit a new 52-week low of Rs. 9,400 today, indicating significant selling pressure.<BR><BR>The stock's performance over various periods shows a consistent underperformance compared to the benchmark Sensex. Over the past week, the stock has decreased by -6.50%, while the Sensex fell by -3.72%. In the last month, the stock's decline of -17.34% is more severe than the Sensex's -12.72%. Year-to-date, the stock has dropped -26.51%, compared to the Sensex's -14.70%. This trend of underperformance has persisted over the last year, with the stock down -31.31% against the Sensex's -5.47%.<BR><BR>Despite some positive factors, such as high management efficiency and recent strong financial results, the long-term growth outlook appears poor, with net sales growing at an annual rate of only 5.52% over the last five years. The stock is also considered expensive with a Price to Book Value of 33.1, and its PEG ratio of 1.8 suggests that, despite rising profits, the stock's valuation may not be justified. <BR><BR>Overall, the combination of recent price declines, consistent underperformance against benchmarks, and concerns regarding long-term growth prospects contribute to the current downward movement in Procter & Gamble Hygiene & Health Care Ltd.'s stock price.

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 24-Mar, Procter & Gamble Hygiene & Health Care Ltd. is seeing a slight stock price increase to Rs. 9,516.00, but it has recently hit a 52-week low and shows significant long-term underperformance with a year-to-date decline of 26.45%. The stock's bearish trend and reduced investor interest further complicate its outlook.

As of 24-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a slight rise in its stock price, currently at Rs. 9,516.00, reflecting an increase of 49.45 (0.52%). This uptick comes after a trend reversal, as the stock has gained after three consecutive days of decline. However, it is important to note that the stock has recently hit a new 52-week low of Rs. 9,338.3, indicating ongoing volatility and challenges.<BR><BR>Despite the current rise, the stock has shown significant underperformance over various periods, with a year-to-date decline of 26.45% and a one-year drop of 31.40%. This underperformance is compounded by the fact that the stock has consistently lagged behind the benchmark indices, including the Sensex, which has only declined by 5.02% over the same period. Additionally, the stock is trading below its moving averages across multiple time frames, suggesting a bearish trend.<BR><BR>Investor participation has also decreased, with delivery volume falling by 63.38% compared to the five-day average, indicating reduced interest from investors. Furthermore, while the company has demonstrated high management efficiency with a return on equity (ROE) of 81.87% and low debt levels, its long-term growth prospects appear poor, with net sales and operating profit growing at only 5.52% and 5.34% annually over the last five years, respectively.<BR><BR>In summary, while there is a minor rise in the stock price today, the overall trend remains concerning due to significant long-term underperformance, declining investor interest, and a recent new low, which all contribute to a challenging outlook for Procter & Gamble Hygiene & Health Care Ltd.

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 25-Mar, Procter & Gamble Hygiene & Health Care Ltd. is seeing a stock price increase to 9,622.20, up 1.31%. However, it has underperformed in the long term, with a year-to-date decline of 25.63% and a significant drop in investor participation.

As of 25-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a rise in its stock price, currently at 9,622.20, with a change of 124.75 (1.31%) upwards. This increase can be attributed to a few factors. Firstly, the stock has shown a consecutive gain over the last two days, rising by 1.64% during this period. Additionally, the stock reached an intraday high of Rs 9750, reflecting positive trading activity.<BR><BR>Despite this recent uptick, it is important to note that the stock has been underperforming in the longer term. Over the past week, it has declined by 4.01%, and in the last month, it has fallen by 15.85%. Year-to-date, the stock is down 25.63%, and over the past year, it has generated a return of -31.31%, significantly underperforming against the benchmark Sensex, which has only declined by 3.52% in the same period.<BR><BR>The stock is also trading below its moving averages across various time frames, indicating a potential bearish trend. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 30.98% against the 5-day average. This decline in trading activity may suggest a lack of confidence among investors despite the recent price increase.<BR><BR>Overall, while the stock is currently rising, it faces significant challenges due to its poor long-term growth metrics and consistent underperformance against benchmarks, which may impact its future price movements.

Which are the latest news on P&G Hygiene?